The global irritable bowel syndrome treatment market size was valued at USD 3.64 billion in 2024 and is anticipated to grow at a CAGR of 8.8% from 2025 to 2030. The market growth is attributed to the increasing prevalence of irritable bowel syndrome (IBS), influenced by stress and unheal... Read More »
October 2024The global interleukin inhibitors market size was estimated at USD 32.5 billion in 2024 and is projected to grow at a CAGR of 17.3% from 2025 to 2030. Rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD) are increasingly prevalent, driving the demand for effective t... Read More »
October 2024The global epigenetics drugs & diagnostic technologies market size was valued at USD 15.4 billion in 2023 and is projected to grow at a CAGR of 14.5% from 2024 to 2030. This growth is attributed to lifestyle-related disorders such as diabetes and obesity and is also used in screening... Read More »
October 2024The global herbal supplements market size was valued at USD 39.3 billion in 2023 and is projected to grow at a CAGR of 7.3% from 2024 to 2030. The market surge can be credited to the major shifts in consumer preferences. Consumers have increasingly recognized the benefits of preventive h... Read More »
October 2024The global amyloidosis treatment market size was valued at USD 5.39 billion in 2023 and is projected to grow at a CAGR of 7.4% from 2024 to 2030. The market growth can be attributed to the rising incidence of amyloidosis among the geriatric population. Amyloidosis is a rare disease chara... Read More »
October 2024The global lymphoma treatment market size was valued at USD 7.41 billion in 2024 and is anticipated to grow at a CAGR of 8.3% from 2025 to 2030. The market growth is attributed to the increasing incidence of lymphoma, particularly non-Hodgkin lymphoma, which has heightened demand for eff... Read More »
October 2024The global personalized testing & supplements market size was valued at USD 10.22 billion in 2023 and is projected to grow at a CAGR of 16.04% from 2024 to 2030. The market has experienced significant growth due to the increasing consumer demand for tailored health solutions. As peop... Read More »
October 2024The global antiarrhythmic drugs market size was valued at USD 1.05 billion in 2023 and is projected to grow at a CAGR of 6.4% from 2024 to 2030. This anticipated growth is driven by several critical factors, including the rising prevalence of cardiovascular diseases, innovations in drug ... Read More »
October 2024The global continuous manufacturing for small molecule APIs market size was valued at USD 335.6 million in 2023 and is projected to grow at a CAGR of 10.42% from 2024 to 2030. This growth is propelled by the rising prevalence of chronic diseases, supportive regulatory frameworks, technol... Read More »
October 2024The global neglected tropical disease treatment market size was valued at USD 3.78 billion in 2023 and is expected to grow at a CAGR of 4.8% from 2024 to 2030. The market growth is attributed to increased government initiatives and rising awareness about neglected tropical diseases (NTDs... Read More »
October 2024The North America hemp-derived cannabidiol market size was valued at USD 1.5 billion in 2024. It is expected to expand at a compound annual growth rate (CAGR) of 13.5% from 2025 to 2030. The growing awareness and adoption of cannabidiol (CBD) for various health conditions are the key fac... Read More »
October 2024The global kidney cancer drugs market size to be valued at USD 6.3 billion by 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.4% during the forecast period. The U.S. dominated the scene among the seven major markets. Market growth is largely driven by factors su... Read More »
October 2024The New York cannabis market size was valued at USD 544.2 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 16.9% from 2024 to 2030. The MRTA act has established a framework for the legal sale of adult-use cannabis, encompassing licensing, taxation, and ... Read More »
September 2024The global breakthrough therapy designation market size was valued at USD 97.4 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 14.2% from 2024 to 2030. It is a process designed to escalate the development and assessment of sanctioning of drugs & bi... Read More »
September 2024The global blockbuster oncology brands market size was valued at USD 40.80 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2030. The increasing incidence of various cancer types across different age demographics, advancements in oncol... Read More »
September 2024The global Systemic Lupus Erythematosus (SLE) market size was valued at USD 2.60 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2030. Increasing new cases of autoimmune diseases, growing prevalence of SLE worldwide, awareness regardi... Read More »
September 2024The global smart pills market size was valued at USD 1.71 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 11.3% from 2024 to 2030. Smart pills, often called digital pills or ingestible sensors, represent a breakthrough in medical technology by combinin... Read More »
September 2024The Latin America (Brazil, Argentina, Chile, Mexico, Colombia, Venezuela) insulin market size was valued at USD 796.7 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 3.3% from 2024 to 2030. The projected growth is attributed to multiple factors, such a... Read More »
September 2024The global pneumonia therapeutics market size was valued at USD 2.28 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2030. The growing incidence of pneumococcal disease is a high impact rendering driver. Over the years, there has been... Read More »
September 2024The global uveitis treatment market size was valued at USD 2.23 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.1% from 2024 to 2030. The growth is due to rising prevalence of uveitis, increased awareness and early diagnosis. The growing R&D acti... Read More »
September 2024